Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anne-Lise Hachulla is active.

Publication


Featured researches published by Anne-Lise Hachulla.


Revista Espanola De Cardiologia | 2017

Thirty-day Outcome Following CoreValve Evolut R Transcatheter Aortic Valve Implantation: An All-comers Prospective Study

Nils Perrin; Marco Roffi; Angela Frei; Anne-Lise Hachulla; Christoph Ellenberger; Hajo Müller; Mustafa Cikirikcioglu; Marc Licker; Stéphane Noble

INTRODUCTION AND OBJECTIVES There are scarce clinical outcomes data on the new generation recapturable and repositionable CoreValve Evolut R. METHODS Data on all-comer patients undergoing transcatheter aortic valve implantation (TAVI) with the Evolut R for severe symptomatic aortic stenosis at a single center were prospectively collected between February 2015 and April 2016. Clinical endpoints were independently adjudicated according to the Valve Academic Research Consortium-2 criteria. Primary outcomes consisted of early safety composite endpoints and 30-day device success. The incidence of new permanent pacemaker implantation was recorded. RESULTS Among the 83 patients undergoing TAVI during this period, 71 (85.5% of the population; median age, 83.0 [interquartile range, 80.0-87.0] years; Society of Thoracic Surgeons scores, 4.8±3.5%) were suitable for Evolut R implantation and were included in the analysis. Repositioning was performed in 26.8% of the procedures. The early safety composite endpoint was observed in 11.3% of patients at 30 days, with 2.8% all-cause mortality. Device success was documented in 90.1% of patients. Paravalvular leakage was less than grade II in 98.4% of patients. The mean transvalvular aortic gradient was reduced from 42.5±14.5mmHg at baseline to 7.7±4.0mmHg at discharge (P<.0001 vs baseline). New permanent pacemaker implantation was required in 23.9% of patients. CONCLUSIONS The new generation Evolut R is suitable for most patients and shows high device success and acceptable mortality in an unbiased, consecutive, all-comer population at a single center performing TAVI exclusively with Medtronic valves.


Swiss Medical Weekly | 2016

Dual-energy computed tomographic imaging of pulmonary hypertension

Anne-Lise Hachulla; Frédéric Lador; Paola M. Soccal; Xavier Montet; Maurice Beghetti

Dual-energy computed tomography (DECT) angiography of the chest provides a combined morphological and functional analysis of the lung, usually obtained in a single acquisition without extra radiation or injection of extra intravenous iodine contrast. The parenchymal iodine maps generated by DECT are well correlated with scintigraphy, and are becoming an essential tool for evaluating patients with pulmonary vascular diseases. With a single DECT acquisition, complete imaging of pulmonary hypertension is now available, displaying vascular anatomy, parenchymal morphology and functional assessment. Triangular pulmonary perfusion defects in chronic thromboembolic pulmonary hypertension may be clearly analysed even in the presence of distal arterial occlusion. Perfusion heterogeneities seen in patients with pulmonary arterial hypertension reflect mosaic perfusion and may be helpful for the diagnosis, severity assessment and prognosis of the disease. Vascular or parenchymal abnormalities can also be analysed with perfusion defects to determine their aetiology. Pulmonary arterial hypertension due to congenital heart disease can be assessed with a single DECT, even in the neonatal population. Furthermore, new applications are emerging with ventilation imaging or myocardial perfusion imaging obtained by DECT and should be considered. In conclusion, DECT of the thorax enables the simultaneous and noninvasive assessment of vascular anatomy, parenchymal morphology and functional pulmonary imaging in various groups of PH.


Canadian Journal of Cardiology | 2018

Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists

Mauro Frigeri; Philippe Meyer; Carlo Banfi; Raphaël Giraud; Anne-Lise Hachulla; David Spoerl; Alex Friedlaender; Angela Pugliesi-Rinaldi; Pierre-Yves Dietrich

The ever-increasing use of immune checkpoint inhibitors in cancer is leading to a high incidence of autoimmune side effects. This report discusses an autoimmune fulminant myocarditis in an elderly patient with metastatic pulmonary adenocarcinoma in whom the most advanced invasive heart failure therapies were used successfully. She was treated with nivolumab. This case illustrates a severe cardiovascular complication of immunotherapy and highlights to cardiologists the importance of aggressive treatments in patients with metastatic cancers whose prognosis has improved dramatically.


Circulation | 2016

Unrestrictive Aortopulmonary Window Extreme Presentation as Non-Eisenmenger in a 30-Year-Old Patient

Patrick Olivier Myers; Frédéric Lador; Anne-Lise Hachulla; Judith Bouchardy; Stéphane Noble; Marc Licker; Jean-Claude Pache; Dimitra Kalimanovaska-Ostric; Milan Djukic; Afksendiyos Kalangos; Maurice Beghetti

A 30-year-old woman was referred for management of an aortopulmonary window. Her history was notable for chronic atrial fibrillation treated by amiodarone and Coumadin anticoagulation. Peripheral oxygen saturation was 95%. A chest x-ray film showed cardiomegaly, bilateral prominent hilar vascularization, and interstitial edema (Figure 1). The echocardiogram showed a large, 15-mm aortopulmonary (AP) window, ≈25 mm above the aortic valve annulus between the ascending aorta and main pulmonary artery (type I) with an unrestrictive, exclusively left-right shunt and a peak gradient of 30 mm Hg (Figure 2). There was no aortic coarctation or interruption of the aortic arch, and the main pulmonary artery (3.3 cm) was dilated to a size equal to the aortic root, with dilated branch pulmonary arteries (2.3 cm each). The left atrium was severely dilated (45 cm2), as was the left ventricle (end-diastolic diameter, 7.5 cm; indexed, 5.2 cm/m2). There was moderate mitral regurgitation (regurgitation volume, 26.6 mL; proximal isovelocity surface area convergence radius, 6.8 mm) attributable to annular dilatation. The biventricular systolic function was normal. The right ventricular systolic pressure was estimated at 63.3 mm Hg by the gradient of the tricuspid regurgitation jet. Cardiac MRI confirmed these findings (Figure 3 …


Acta radiologica short reports | 2016

Influence of model based iterative reconstruction algorithm on image quality of multiplanar reformations in reduced dose chest CT

Heloise Barras; Vincent Dunet; Anne-Lise Hachulla; Jochen Grimm; Catherine Beigelman-Aubry

Background Model-based iterative reconstruction (MBIR) reduces image noise and improves image quality (IQ) but its influence on post-processing tools including maximal intensity projection (MIP) and minimal intensity projection (mIP) remains unknown. Purpose To evaluate the influence on IQ of MBIR on native, mIP, MIP axial and coronal reformats of reduced dose computed tomography (RD-CT) chest acquisition. Material and Methods Raw data of 50 patients, who underwent a standard dose CT (SD-CT) and a follow-up RD-CT with a CT dose index (CTDI) of 2–3 mGy, were reconstructed by MBIR and FBP. Native slices, 4-mm-thick MIP, and 3-mm-thick mIP axial and coronal reformats were generated. The relative IQ, subjective IQ, image noise, and number of artifacts were determined in order to compare different reconstructions of RD-CT with reference SD-CT. Results The lowest noise was observed with MBIR. RD-CT reconstructed by MBIR exhibited the best relative and subjective IQ on coronal view regardless of the post-processing tool. MBIR generated the lowest rate of artefacts on coronal mIP/MIP reformats and the highest one on axial reformats, mainly represented by distortions and stairsteps artifacts. Conclusion The MBIR algorithm reduces image noise but generates more artifacts than FBP on axial mIP and MIP reformats of RD-CT. Conversely, it significantly improves IQ on coronal views, without increasing artifacts, regardless of the post-processing technique.


European Heart Journal | 2015

Left ventricular free wall rupture contained by an apical pseudo-aneurysm

Burak Can Depboylu; Anne-Lise Hachulla; Ariane Testuz; Mustafa Cikirikcioglu

A 76-year-old male patient was admitted for exertional shortness of breath for the last month. Physical examination showed bipulmonary hypoventilation and fine crackles. The electrocardiogram was compatible with sequelae of anterior myocardial infarction, with borderline troponin-T levels, and no elevation of creatinine-kinase. Transthoracic echocardiography confirmed a large anterior myocardial …


Open Heart | 2018

Conduction disorders using the Evolut R prosthesis compared with the CoreValve: has anything changed?

Nils Perrin; Tilman Perrin; Anne-Lise Hachulla; Angela Frei; Hajo Müller; Marco Roffi; Mustafa Cikirikcioglu; Christoph Ellenberger; Marc-Joseph Licker; Haran Burri; Stéphane Noble

Aim We compared early postprocedural and midterm evolution of atrioventricular and intraventricular conduction disorders following implantation of the new generation Evolut R (ER) prosthesis in comparison with the previous generation CoreValve (CV) system using routinely recorded ECG up to 6-month follow-up. Methods All consecutive patients treated by transcathether aortic valve implantation (TAVI) using the Medtronic self-expanding devices for symptomatic severe aortic stenosis in a single centre between October 2011 and February 2016 were considered for inclusion. ECGs recorded at baseline, day 1 after TAVI, discharge and 6 months were retrospectively analysed. At each time-point, intrinsic rhythm, PR interval, QRS axis and duration, and atrioventricular and intraventricular conduction were analysed. Atrioventricular and intraventricular conduction following TAVI at discharge and at 6 months were compared intrasubject at the different time intervals and between patients receiving the ER versus the CV prosthesis. Results Among the 113 patients included in the analysis (51% female, 83.3±6.2 years), 60 (53%) patients received the CV and 53 (47%) patients received the ER. Compared with patients in the CV group, those in the ER group had a lower Society of Thoracic Surgeons score (6.3±3.1vs 4.8±3.6, P=0.02). Patients in the ER group in comparison with those in the CV group more frequently had postprocedural PR interval (57%vs23%, respectively, P=0.004) and QRS prolongation (76%vs50%, P=0.03) at discharge. Incidence of complete atrioventricular block was similar between both groups (9%vs18%, P=0.3) up to 6-month follow-up. No difference in term of new left bundle branch block (LBBB) (34%vs28%, P=0.8) or permanent pacemaker implantation rates (32.1%vs31.7%, P=1.0) was reported. Conclusions Patients with the ER had greater postprocedural atrioventricular and intraventricular conduction delays than those with the CV at discharge, with however similar incidence of high-degree atrioventricular block, new LBBB and permanent pacemaker implantation up to 6-month follow-up.


Insights Into Imaging | 2018

Radiological findings of complications after lung transplantation

Céline Habre; Paola M. Soccal; Frédéric Triponez; John-David Aubert; Thorsten Krueger; Steve P. Martin; Joanna Gariani; Jean-Claude Pache; Frédéric Lador; Xavier Montet; Anne-Lise Hachulla

Complications following lung transplantation may impede allograft function and threaten patient survival. The five main complications after lung transplantation are primary graft dysfunction, post-surgical complications, alloimmune responses, infections, and malignancy. Primary graft dysfunction, a transient ischemic/reperfusion injury, appears as a pulmonary edema in almost every patient during the first three days post-surgery. Post-surgical dysfunction could be depicted on computed tomography (CT), such as bronchial anastomosis dehiscence, bronchial stenosis and bronchomalacia, pulmonary artery stenosis, and size mismatch. Alloimmune responses represent acute rejection or chronic lung allograft dysfunction (CLAD). CLAD has three different forms (bronchiolitis obliterans syndrome, restrictive allograft syndrome, acute fibrinoid organizing pneumonia) that could be differentiated on CT. Infections are different depending on their time of occurrence. The first post-operative month is mostly associated with bacterial and fungal pathogens. From the second to sixth months, viral pneumonias and fungal and parasitic opportunistic infections are more frequent. Different patterns according to the type of infection exist on CT. Malignancy should be depicted and corresponded principally to post-transplantation lymphoproliferative disease (PTLD). In this review, we describe specific CT signs of these five main lung transplantation complications and their time of occurrence to improve diagnosis, follow-up, medical management, and to correlate these findings with pathology results.Key Points• The five main complications are primary graft dysfunction, surgical, alloimmune, infectious, and malignancy complications.• CT identifies anomalies in the setting of unspecific symptoms of lung transplantation complications.• Knowledge of the specific CT signs can allow a prompt diagnosis.• CT signs maximize the yield of bronchoscopy, transbronchial biopsy, and bronchoalveolar lavage.• Radiopathological correlation helps to understand CT signs after lung transplantation complications.


European Radiology | 2018

3D-printed heart model to guide LAA closure: useful in clinical practice?

Anne-Lise Hachulla; Stéphane Noble; Gabriel Guglielmi; Daniel Agulleiro; Hajo Müller; Jean-Paul Vallée

ObjectivesCorrect device sizing for left atrial appendage (LAA) closure remains challenging due to complex LAA shapes. The aim of our study was to investigative the utility of personalized 3D-printed models (P3DPM) of the LAA to guide device size selection.MethodsFifteen patients (75.4 ±8.5years) scheduled for LAA closure using an Amulet device underwent cardiac computed tomography (CT). The LAA was segmented by semiautomatic algorithms using Vitrea® software. A 1.5-mm LAA thick shell was exported in stereolithography format and printed using TangoPlus flexible material. Different Amulet device sizes on the P3DPM were tested. New P3DPM-CT with the device was acquired in order to appreciate the proximal disc sealing the LAA ostium and the compression of the distal lobe within the LAA. We predicted the device size with P3DPM and compared this with the device sizes predicted by transesophageal echocardiography (TEE) and CT as well as the device size implanted in patients.ResultsThe device size predicted by 3D-TEE and CT corresponded to the implanted device size in 8/15 (53%) and 10/15 (67%), respectively. The predicted device size from the P3DPM was accurate in all patients, obtaining perfect contact with the LAA wall, without device instability or excessive compression. P3DPM-CT with the deployed device showed device deformation and positioning of the disk in relation to the pulmonary veins, allowing us to determine the best device size in all 15 cases.ConclusionP3DPM allowed us to simulate the LAA closure procedure and thus helped to identify the best Amulet size and position within the LAA.Key Points• A 3D-printed heart model allows to simulate the LAA closure procedure.• A 3D-printed heart model allowed to identify the optimal Amulet size and position.• 3D-printed heart models may contribute to reduce the Amulet implantation learning curve.


Academic Radiology | 2018

Low Iodine Contrast Injection for CT Acquisition Prior to Transcatheter Aortic Valve Replacement: Aorta Assessment and Screening for Coronary Artery Disease

Anne-Lise Hachulla; Stéphane Noble; Maxime Ronot; Gabriel Guglielmi; Thomas Benoît De Perrot; Xavier Montet; Jean-Paul Vallée

RATIONALE AND OBJECTIVES To assess both the complete aorta and coronary artery disease (CAD) using low iodine contrast computed-tomography angiography before transcatheter aortic valve replacement. MATERIALS AND METHODS 84 patients underwent computed-tomography angiography before transcatheter aortic valve replacement: 42 with standard iodine injection protocol (P1:120 mL); 42 with a low dose iodine injection protocol (P2:60 mL). Mean attenuation and subjective image quality were rated at different levels of the aorta, iliac and coronary arteries. Sensitivity, specificity, negative and positive predictive values for depiction of CAD were calculated according to the coronary angiography. RESULTS Mean attenuation was significantly higher in P1 for the ascending aorta (p < 0.001). No significant difference was observed regarding image quality of the aortic valve (p = 0.876), the ascending aorta (p = 0.306), or the abdominal aorta (p = 1.0). Diagnostic image quality of coronary arteries was excellent for P1 and P2 (94.6% vs 96.5%, p = 0.08). Sensitivity, specificity, negative and positive predictive values, and accuracy for depiction of CAD were excellent for P1 and P2 (100% vs 100%; 79% vs 86%, 70% vs 87%, 100% vs 100% and 86% vs 93%) without significant differences (p = 0.93; p = 0.58; p = 0.90; p = 1.0; p = 0.74), respectively. CONCLUSION Despite a difference in aortic mean attenuation, a reduced iodine injection protocol showed similar image quality and detection of CAD in comparison with a standard injection protocol.

Collaboration


Dive into the Anne-Lise Hachulla's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge